Viewing Study NCT03272334


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-02-28 @ 8:50 PM
Study NCT ID: NCT03272334
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-27
First Post: 2017-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
Sponsor: University of Virginia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module